Andrew Bottomley

Active 1995–2025

124
Papers
21,237
Citations
81
h-index
118
i10-index

Citations

Citations per year for Andrew Bottomley1996: 1 citations1997: 6 citations1998: 7 citations1999: 5 citations2000: 16 citations2001: 6 citations2002: 18 citations2003: 30 citations2004: 45 citations2005: 70 citations2006: 64 citations2007: 112 citations2008: 95 citations2009: 115 citations2010: 121 citations2011: 162 citations2012: 143 citations2013: 179 citations2014: 131 citations2015: 125 citations2016: 139 citations2017: 144 citations2018: 144 citations2019: 677 citations2020: 684 citations2021: 573 citations2022: 471 citations2023: 296 citations2024: 646 citations2025: 246 citations2026: 7 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,383 citing papers, 15% of this breakdownUnited Kingdom: 841 citing papers, 9.1% of this breakdownNetherlands: 709 citing papers, 7.7% of this breakdownGermany: 672 citing papers, 7.3% of this breakdownItaly: 488 citing papers, 5.3% of this breakdownFrance: 436 citing papers, 4.7% of this breakdownAustralia: 409 citing papers, 4.4% of this breakdownCanada: 408 citing papers, 4.4% of this breakdownBelgium: 347 citing papers, 3.7% of this breakdownSpain: 294 citing papers, 3.2% of this breakdownChina: 279 citing papers, 3% of this breakdownSweden: 252 citing papers, 2.7% of this breakdown
0%15%Other 29.5%

Fields

  • Medicine85.2%
  • Biochemistry, Genetics and Molecular Biology3.2%
  • Economics, Econometrics and Finance2.7%
  • Health Professions2.3%
  • Psychology1.6%
  • Social Sciences0.8%
  • Other4.2%

Topics

  • Cancer survivorship and care11.9%
  • Brain Metastases and Treatment3.1%
  • Glioma Diagnosis and Treatment3.1%
  • Cancer-related cognitive impairment studies3.1%
  • Palliative Care and End-of-Life Issues2.1%
  • Childhood Cancer Survivors' Quality of Life2.1%
  • Other74.6%

Coauthors

All papers

Open in search
  1. EORTC QLQ-C30 Scoring Manual

    Authors: , , , , , - 1995 cited by 2,421

  2. Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Brundage, Michael Palmer, Paul G. Kluetz, Richard Stephens, Robert Golub, Sandra A. Mitchell, Trish Groves - JAMA 2018 cited by 798

  3. Quality of life research within the EORTC—the EORTC QLQ-C30

    Authors: , - European Journal of Cancer 2002 cited by 915

  4. International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ashley Wilder Smith, Katherine M Soltys, Martin Taphoorn, Galina Velikova, Andrew Bottomley - The Lancet Oncology 2020 cited by 306

  5. Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types

    Authors: , , , , , , , , , , , , , , , , , , , - European Journal of Cancer 2023 cited by 174

  6. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials

    Authors: , , , , , , , , - The Lancet Oncology 2009 cited by 653

  7. Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancer

    Authors: , , , , , , , , , , , , , , , , , - European Journal of Cancer 2022 cited by 157

  8. Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elektra J. Papadopoulos, Kavita Sail, Rohini Sen, Sean Turner, Kim Cocks, Jaap C. Reijneveld, Christoph Gerlinger, Karen Keating, Yun Su, Birgit Wolf, Miaomiao Ge, Anders Ingelgaard, Barbara Peil, Maarten Voorhaar, Brendon Wong, Gracia Dekanic Arbanas, Karin Kuljanić, Duška Petranović, Ivana Rede, Juan Ignacio Arrarás, Stephen Joel Coons, Sonya Eremenco, Lindsey Murray, Bryce B. Reeve, Corinne S de Vries, Ralf Herold, Francesco Pignatti, Abigirl Machingura, Francesca Martinelli, Jammbe Musoro, Martine Piccart, Jorge Barriuso, Nathan I. Cherny, Urania Dafni, Elisabeth G.E. de Vries, Bishal Gyawali, Barbara Kiesewetter, Sjoukje F. Oosting, Felipe Roitberg, Gerhard Rumpold, Felix Schoepf, Michael Tschuggnall, Jennifer A. Black, Maxime Sasseville, Katherine M Soltys, Montserrat Ferrer, Olatz Garín, Gemma Vilagut, Christoph Schürmann, Stefanie M. Thomas, Beate Wieseler, Claire Snyder, Ariel Alonso Abad, Kris Bogaerts, Febe Brackx, Geert Molenberghs, Geert Verbeke, Cristián Frigolett Catalan, Jan Choi, Doranne Thomassen, Jan Geißler, Willi Sauerbrei, Franziska Gross, Micha J. Pilz, Yolanda Barbáchano, Lisa Campbell, Khadija Rantell, Gregoire Desplanques, Antoine Regnault, Kate Morgan and 41 more - The Lancet Oncology 2023 cited by 57

  9. Recommendations to address respondent burden associated with patient-reported outcome assessment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Khadija Rantell, Antoine Regnault, Maxime Sasseville, Liv Marit Valen Schougaard, Roya Sherafat‐Kazemzadeh, Claire Snyder, Angela M. Stover, Rav Verdi, Roger Wilson, Melanie Calvert - Nature Medicine 2024 cited by 116

  10. The development of the EORTC QLQ-C15-PAL: A shortened questionnaire for cancer patients in palliative care

    Authors: , , , , , , , , , , , - European Journal of Cancer 2005 cited by 689

  11. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients

    Authors: , , , , , , , , , - European Journal of Cancer 2010 cited by 392

  12. The Prognostic Significance of Patient-Reported Outcomes in Cancer Clinical Trials

    Authors: , , , - Journal of Clinical Oncology 2008 cited by 655

  13. International Psychometric Validation of an EORTC Quality of Life Module Measuring Cancer Related Fatigue (EORTC QLQ-FA12)

    Authors: , , , , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2016 cited by 184

  14. An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Koller, Eva Nagele, Ourania Nicolatou‐Galitis, Anne Oberguggenberger, Claudia Schmalz, Zoë Winters - Annals of Oncology 2020 cited by 145

  15. Recommendations on the use of item libraries for patient-reported outcome measurement in oncology trials: findings from an international, multidisciplinary working group

    Authors: , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2023 cited by 68

  16. Minimally Important Differences for Interpreting EORTC QLQ-C30 Scores in Patients With Advanced Breast Cancer

    Authors: , , , , , , , , , , , , , - JNCI Cancer Spectrum 2019 cited by 114

  17. Quality of life as a prognostic indicator of survival: A pooled analysis of individual patient data from canadian cancer trials group clinical trials

    Authors: , , , , , , , , , , , , , , , - Cancer 2018 cited by 99

  18. Linking the European Organisation for Research and Treatment of Cancer Item Library to the Common Terminology Criteria for Adverse Events

    Authors: , , , , , , - Journal of Clinical Oncology 2022 cited by 55

  19. A European Organisation for Research and Treatment of Cancer Phase III Trial of Adjuvant Whole-Brain Radiotherapy Versus Observation in Patients With One to Three Brain Metastases From Solid Tumors After Surgical Resection or Radiosurgery: Quality-of-Life Results

    Authors: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2012 cited by 645

  20. An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancer

    Authors: , , , , , , , , , , , - European Journal of Cancer 2008 cited by 485

  21. Current state of quality of life and patient-reported outcomes research

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anne‐Sophie Darlington, Ian Lewis, Lonneke V. van de Poll‐Franse - European Journal of Cancer 2019 cited by 178

  22. Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review

    Authors: , , , , , , , , , , , , - The Lancet Oncology 2019 cited by 129

  23. Reference values for the EORTC QLQ-C30 in early and metastatic breast cancer

    Authors: , , , , , , , , , , , , , , , - European Journal of Cancer 2019 cited by 75

  24. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michal Kiciński, Stefan Suciu, Caroline Robert, Alexander M.M. Eggermont, Thierry Lesimple, Michele Maio, Gerald P. Linette, Laurent Mortier, Inge Marie Svane, Jacob Schachter, Michael P. Brown, Peter Hersey, Catherine Barrow, Ragini R. Kudchadkar, Caroline Dutriaux, Xinni Song, Pietro Quaglino, Paola Queirolo, Friedegund Meier, Daniil Stroyakovskiy, B. Guillot, Pablo L. Ortiz‐Romero, Lars Bastholt, Claus Garbe, Florent Grange, Peter Mohr, Alain P. Algazi, Oliver Bechter, Micaela Hernberg, Carmen Loquai, Frank Meiß, Vanna Chiarion‐Sileni, Gil Bar‐Sela, Bernard M. Fitzharris, Philippe Saïag, Jean‐Philippe Arnault, Jan‐Christoph Simon, Rosalie Stephens, Jean‐François Baurain, Célèste Lebbé, P. Combemale, Reinhard Dummer, Axel Hauschild, Phillip Parente, Naoya Yamazaki, Mohammed Milhem, M.‐T. Leccia, L. Geoffrois, Lutz Kretschmer, Elaine Dunwoodie, John Walker, Michal Lotem, Daniel Hendler, Andrzej Maćkiewicz, Lidija Kandolf Sekulović, Marcin Dzienis, Geke A.P. Hospers, Marco Siano, Jessica C. Hassel, Philippa Corrie, Maria-Jose Passos, Max Levin, Christoph Höeller, L. Machet, Sigrun Hallmeyer, Ashita Waterston, V. Descamps, Felix Kiecker, Maureen J.B. Aarts, Henrik Schmidt and 34 more - The Lancet Oncology 2021 cited by 72